BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16485127)

  • 21. Interferon-alpha-induced protection of renal cell cancer cell line from lysis by natural killer cells and increase of susceptibility by treatment with 5-fluorouracil.
    Imai T; Katagiri A; Saito K; Tomita Y
    Cancer Lett; 1995 Aug; 94(2):191-7. PubMed ID: 7634247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.
    Booy S; van Eijck CH; Dogan F; van Koetsveld PM; Hofland LJ
    J Cell Mol Med; 2014 Mar; 18(3):492-502. PubMed ID: 24460759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors.
    Vitale G; van Eijck CH; van Koetsveld Ing PM; Erdmann JI; Speel EJ; van der Wansem Ing K; Mooij DM; Colao A; Lombardi G; Croze E; Lamberts SW; Hofland LJ
    Ann Surg; 2007 Aug; 246(2):259-68. PubMed ID: 17667505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.
    Kaser A; Enrich B; Ludwiczek O; Vogel W; Tilg H
    Clin Exp Immunol; 1999 Oct; 118(1):71-7. PubMed ID: 10540162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
    Schwaab T; Heaney JA; Schned AR; Harris RD; Cole BF; Noelle RJ; Phillips DM; Stempkowski L; Ernstoff MS
    J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of pancreatic cancer cells treated with interferon-alpha or beta and co-exposed to ionising radiation.
    Jöst E; Roos WP; Kaina B; Schmidberger H
    Int J Radiat Biol; 2010 Sep; 86(9):732-41. PubMed ID: 20586542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes.
    Bergmann-Leitner ES; Abrams SI
    Cancer Immunol Immunother; 2001 Nov; 50(9):445-55. PubMed ID: 11761438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES; Abrams SI
    J Immunol; 2000 May; 164(9):4941-54. PubMed ID: 10779805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interferon-α mediating the functional damage of CD56
    Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis.
    Detjen KM; Farwig K; Welzel M; Wiedenmann B; Rosewicz S
    Gut; 2001 Aug; 49(2):251-62. PubMed ID: 11454803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
    Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
    J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.
    Ohashi M; Yoshida K; Kushida M; Miura Y; Ohnami S; Ikarashi Y; Kitade Y; Yoshida T; Aoki K
    Br J Cancer; 2005 Aug; 93(4):441-9. PubMed ID: 16106250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759].
    Hoffmann K; Marten A; Lindel K; Fritz S; Jager D; Buchler MW; Schmidt J
    BMC Cancer; 2006 May; 6():128. PubMed ID: 16686958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 2 and interferon alpha-2a do not improve anti-tumour activity of 5-fluorouracil in advanced colorectal cancer.
    Goey SH; Gratama JW; Primrose JN; Ward U; Mertelsmann RH; Osterwalder B; Verweij J; Stoter G
    Br J Cancer; 1996 Dec; 74(12):2018-23. PubMed ID: 8980407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8.
    Adachi Y; Taketani S; Oyaizu H; Ikebukuro K; Tokunaga R; Ikehara S
    Int J Oncol; 1999 Dec; 15(6):1191-6. PubMed ID: 10568827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.
    Lion E; Smits EL; Berneman ZN; Van Tendeloo VF
    J Immunol Methods; 2009 Oct; 350(1-2):89-96. PubMed ID: 19733573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function.
    Jiang W; Zhang C; Tian Z; Zhang J
    Gene Ther; 2013 Nov; 20(11):1062-9. PubMed ID: 23759701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial.
    Katz MH; Wolff R; Crane CH; Varadhachary G; Javle M; Lin E; Evans DB; Lee JE; Fleming JB; Pisters PW
    Ann Surg Oncol; 2011 Dec; 18(13):3615-22. PubMed ID: 21701927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.